SEC Comment Letter 0000000000-23-000303 to WINDTREE THERAPEUTICS INC /DE/ (WINT)

WINDTREE THERAPEUTICS INC /DE/
Date: Jan. 12, 2023 · CIK: 0000946486 · Accession: 0000000000-23-000303

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-39290

Date

January 12, 2023

Author

John Hamill

Form

UPLOAD

Company

WINDTREE THERAPEUTICS INC /DE/

Letter

United States securities and exchange commission logo January 12, 2023 John Hamill Chief Financial Officer WINDTREE THERAPEUTICS INC /DE/ 2600 Kelly Road, Suite 100 Warrington, PA 18976 Re:WINDTREE THERAPEUTICS INC /DE/ Preliminary Proxy Statement on Schedule 14A Filed November 22, 2022, as amended File No. 001-39290 Dear John Hamill: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jennifer Porter

Show Raw Text

United States securities and exchange commission logo
January 12, 2023
John Hamill
Chief Financial Officer
WINDTREE THERAPEUTICS INC /DE/
2600 Kelly Road, Suite 100
Warrington, PA 18976
Re:WINDTREE THERAPEUTICS INC /DE/
Preliminary Proxy Statement on Schedule 14A
Filed November 22, 2022, as amended
File No. 001-39290
Dear John Hamill:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Jennifer Porter

SecProbe.io